Device for Alleviating Temporomandibular Joint (TMJ) Pain
NCT: NCT07624539 · COMPLETED
Brief Summary
The goal of this clinical trial is to evaluate the safety and effectiveness of the investigational BTL-043 device in alleviating Temporomandibular Joint (TMJ) pain in adults aged 22 years and older. The main questions it aims to answer are: Does the BTL-043 device effectively reduce TMJ pain? Does the treatment improve jaw mobility (mandibular range of motion) and reduce the impact of TMJ disorders on daily activities? Is the treatment comfortable and safe for participants? Participants will: Receive four 20-minute treatments with the BTL-043 laser, spaced 2 to 10 days apart. Attend follow-up clinic visits 1 month and 3 months after their final treatment. Complete questionnaires about their pain levels (Visual Analogue Scale), daily activities (TMD Disability Index), and treatment comfort and satisfaction. Have their jaw mobility (mandibular range of motion) measured
Frequently Asked Questions
What is Device for Alleviating Temporomandibular Joint (TMJ) Pain?
Device for Alleviating Temporomandibular Joint (TMJ) Pain is a clinical trial registered under NCT07624539. Current status: COMPLETED.
What is the status of NCT07624539?
The current status of NCT07624539 (Device for Alleviating Temporomandibular Joint (TMJ) Pain) is: COMPLETED.
When did Device for Alleviating Temporomandibular Joint (TMJ) Pain start?
Device for Alleviating Temporomandibular Joint (TMJ) Pain started on 2024-08-21.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.